MKI67 and intestinal neuroendocrine neoplasm: Loco-regional therapy followed by surgery (96% consensus) and RLT followed by surgery in the event of response (81% consensus) were also considered appropriate in intestinal NETs, with Ki-67 ≤10%, SSTR expression, and resectable “borderline” liver metastases.